| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 4143- | Ex, | Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4141- | Ex, | Effects of exercise on brain-derived neurotrophic factor in Alzheimer's disease models: A systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 4139- | Ex, | Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases |
| - | Review, | AD, | NA |
| 4145- | Ex, | Effects of different physical activities on brain-derived neurotrophic factor: A systematic review and bayesian network meta-analysis |
| - | Review, | AD, | NA |
| 4069- | FA, | Folate, folic acid and 5-methyltetrahydrofolate are not the same thing |
| - | Review, | AD, | NA |
| 2173- | FA, | VitB12, | Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer |
| - | Study, | CRC, | NA |
| 2176- | FA, | VitB12, | Hyperhomocysteinemia and Cancer: The Role of Natural Products and Nutritional Interventions |
| - | Review, | Var, | NA |
| 2174- | FA, | VitB12, | Homocysteine Levels in Cancer Patients And its Correlation with Vitamin B12 And Folicacid |
| - | Analysis, | Var, | NA |
| 6956- | FA, | VitB12, | A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients |
| - | Trial, | AD, | NA |
| 6960- | FA, | VitA,RetA, | VitC, | VitD3, | VitE | Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies |
| - | Review, | CRC, | NA |
| 1622- | FA, | Folate and Its Impact on Cancer Risk |
| - | Review, | NA, | NA |
| 6853- | FBZ, | Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 6854- | FBZ, | Fenbendazole and its synthetic analog interfere with HeLa cells' proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway |
| - | in-vitro, | Cerv, | HeLa |
| 6859- | FBZ, | DCA, | Synergistic anti-tumor effect of fenbendazole and diisopropylamine dichloroacetate in immunodeficient BALB/c nude mice transplanted with A549 lung cancer cells |
| - | in-vivo, | Lung, | A549 |
| 2499- | FBZ, | VitE, | Effects of fenbendazole and vitamin E succinate on the growth and survival of prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 2498- | FBZ, | Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins |
| - | in-vivo, | lymphoma, | NA |
| 2495- | FBZ, | Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells |
| - | in-vitro, | Melanoma, | A375 |
| 2496- | FBZ, | Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H460 |
| 6892- | Fer, | MR Imaging of Tumor Associated Macrophages with Clinically-Applicable Iron Oxide Nanoparticles |
| - | in-vivo, | Var, | NA |
| 1915- | Fer, | Vascular Imaging With Ferumoxytol as a Contrast Agent |
| - | Analysis, | Var, | NA |
| 2847- | FIS, | Fisetin-induced cell death, apoptosis, and antimigratory effects in cholangiocarcinoma cells |
| - | in-vitro, | CCA, | NA |
| 2849- | FIS, | Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells |
| - | in-vitro, | Melanoma, | U266 |
| 2855- | FIS, | Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells |
| - | in-vitro, | RCC, | Caki-1 |
| 2856- | FIS, | N -acetyl- L -cysteine enhances fisetin-induced cytotoxicity via induction of ROS-independent apoptosis in human colonic cancer cells |
| - | in-vitro, | Colon, | COLO205 |
| 2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 2842- | FIS, | Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells |
| - | in-vitro, | GC, | AGS |
| - | in-vivo, | Nor, | NA |
| 5392- | FIS, | AsP, | Fisetin topical delivery via ascorbyl palmitate/hyaluronan-enhanced limosomes: a novel paradigm for preventing UVB-induced skin photoaging |
| - | in-vivo, | Nor, | NA |
| 2642- | Flav, | QC, | Api, | KAE, | MCT | In Vitro–In Vivo Study of the Impact of Excipient Emulsions on the Bioavailability and Antioxidant Activity of Flavonoids: Influence of the Carrier Oil Type |
| - | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
| 4107- | FLS, | Ex, | Combined effects of aerobic exercise and 40-Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3×Tg mice |
| - | in-vivo, | AD, | NA |
| 6979- | Form, | Pharmacokinetics and Bioavailability of the Isoflavones Formononetin and Ononin and Their in Vitro Absorption in Ussing Chamber and Caco-2 Cell Models |
| - | in-vitro, | Colon, | Caco-2 |
| 6982- | Form, | Formononetin: A Review of Its Anticancer Potentials and Mechanisms |
| - | Review, | Var, | NA |
| 6983- | Form, | Formononetin enhances angiogenesis in diabetic wounds by inhibiting ferroptosis through suppression of mtROS-mediated xCT/GPX4 upregulation |
| - | vitro+vivo, | Nor, | HUVECs | - | vitro+vivo, | Diabetic, | NA |
| 6963- | Form, | Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | T47D |
| 6971- | Form, | In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa |
| - | vitro+vivo, | Cerv, | HeLa |
| 6972- | Form, | PacT, | Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy |
| - | in-vivo, | BC, | MDA-MB-231 |
| 6973- | Form, | Formononetin enhances the chemosensitivity of triple negative breast cancer via BTB domain and CNC homolog 1-mediated mitophagy pathways |
| - | Human, | BC, | NA |
| 6974- | Form, | Formononetin Defeats Multidrug-Resistant Cancers by Induction of Oxidative Stress and Suppression of P-Glycoprotein |
| - | in-vitro, | Cerv, | HeLa |
| 6975- | Form, | Formononetin inhibits colorectal cancer via the miR-490-3p/ABCC2 axis and synergizes with 5-fluorouracil: mechanistic insights and therapeutic implications |
| - | vitro+vivo, | CRC, | NA |
| - | in-vivo, | BPH, | NA |
| 8588- | FS, | Tam, | Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women |
| - | in-vivo, | BC, | NA |
| 8584- | FS, | Anti-Oxidant and Anti-Cancer Properties of Flaxseed |
| - | Review, | Nor, | NA |
| 8581- | FS, | Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations |
| - | in-vivo, | Nor, | NA |
| 8579- | FS, | IP6, | Flaxseed: a potential source of food, feed and fiber |
| - | Review, | Nor, | NA | - | Review, | IBD, | NA |
| 8587- | FS, | Rad, | Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer |
| - | Trial, | Lung, | NA |
| 8601- | FSO, | Differential Response of Two Human Breast Cancer Cell Lines to the Phenolic Extract from Flaxseed Oil |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF-10AT |
| 7018- | Fuc, | Absorption Study of Mozuku Fucoidan in Japanese Volunteers |
| - | Trial, | Nor, | NA |
| 7022- | Fuc, | Antitumor Effects of Fucoidan on Human Colon Cancer Cells via Activation of Akt Signaling |
| - | in-vitro, | Colon, | HT29 |
| 7005- | Fuc, | Fucoidan and cancer: a multifunctional molecule with anti-tumor potential |
| - | Review, | Var, | NA |
| 7006- | Fuc, | Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug—A Review |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid